N@N

Bioinnovation Leader Novozymes Selects PROS Pricing Software to Support Profit Initiative

^{Published on 2011-06-21 04:15:33 - Market Wire}
 

HOUSTON--([ BUSINESS WIRE ])--PROS (NYSE: PRO), the world leader in pricing and revenue management software, today announced that Novozymes, a leading bioinnovation company based in Denmark, selected PROS software as a key enabler to implement a profit improvement initiative as it expands its global footprint.

"The power of prescriptive pricing provides organizations with a strategic enabler to increase profitability as stakeholders look to companies for greater accountability in their business operations. As a global biotechnology leader, Novozymes is setting a new course for its business operations by embarking on its pricing journey."

With $1.8 billion in annual revenue, [ Novozymes ] ([ http://www.novozymes.com ]) is an international leader in the development, production, distribution and sale of enzymes used in a variety of industries from agriculture to consumer products. Novozymes offers bioinnovative products, including industrial enzymes, beneficial microorganisms, biopolymers and other proteins.

aAfter a thorough evaluation of pricing software vendors, Novozymes selected PROS as the optimum solution and partner to support our growth and profit improvement initiatives,a said Novozymes Chief Marketing Officer Henrik Meyer, who also leads the companya™s strategic pricing strategies. aThe PROS low-risk implementation approach, its focus on delivering value quickly, and its endorsements by high-credibility customers and industry thought leaders, gave us confidence that they were the right choice for a long-term partnership. Through this strategic implementation, our sales teams will be empowered to be successful with far better transparency and guidance as they work in partnership with our customers.a

Novozymes is leveraging all three advanced pricing modules incorporated in the PROS Pricing Solution Suite, including [ Scientific Analytics ]a", [ Price Optimizer ]a" and [ Deal Optimizer ]a". The three modules seamlessly work together to support the entire pricing lifecycle, from identifying pricing opportunities, to setting pricing strategies and executing optimized prices. With PROS, customers are able to improve revenue and profitability, defend and grow market share, and improve business agility.

aNovozymes is recognized worldwide for its innovative technologies and commitment to more sustainable and eco-efficient solutions, and wea™re honored to have been selected to help drive their profitable growth efforts,a said PROS Europe General Manager Wagner Williams. aLike PROS, Novozymes makes substantial investments in research and development as the engine to help propel growth.a

aOne of the biggest challenges for innovative companies is making timely pricing decisions in a climate of rapid growth and increasing global competition,a said PROS President and CEO Andres Reiner. aThe power of prescriptive pricing provides organizations with a strategic enabler to increase profitability as stakeholders look to companies for greater accountability in their business operations. As a global biotechnology leader, Novozymes is setting a new course for its business operations by embarking on its pricing journey.a

About Novozymes

Novozymes is a bioinnovation company based in Denmark, producing industrial enzymes, microorganisms, and biopharmaceutical ingredients for a variety of businesses. Novozymes employs more than 5,000 people developing products for industries that include bioenergy, agriculture, household products, textiles, and food and beverages. Novozymes biological solutions help companies make more from less with solutions that save energy and raw materials, and reduce waste. The result is higher quality, lower costs, lower CO₂ emissions and a better environment.

About PROS

PROS Holdings, Inc. ([ NYSE: PRO ]) is a leading provider of prescriptive enterprise pricing and revenue management [ software products ], specializing in price analytics, price execution, and price optimization. By using PROS' software products, companies gain insight into their pricing strategies, identify pricing-based profit leaks, optimize their pricing decision making and improve their business processes and financial performance. PROS' software products implement [ advanced pricing science ], which includes operations research, forecasting and statistics. PROS high performance [ software architecture ] supports real-time high volume transaction processing and allows PROS to handle the processing and database requirements of the most sophisticated and largest customers, including customers with hundreds of simultaneous users and sub-second electronic transactions.

PROS provides [ professional services ] to configure its software products to meet the specific pricing needs of each customer. PROS has implemented over 500 solutions across a range of industries in more than 50 countries.

Founded in 1985, PROS is headquartered in Houston, Texas. Today, PROS has over 400 employees, more than 100 with advanced degrees and over 25 with Ph.D.s. To learn more about PROS, please visit [ www.prospricing.com ].

Forward-looking Statements

This press release contains forward-looking statements, including statements aboutthe functionality of the PROS products and their ability to manage and forecast across an enterprise. The forward-looking statements contained in this press release are based upon PROS' historical performance and its current plans, estimates and expectations, and are not a representation that such plans, estimates or expectations will be achieved. Factors that could cause actual results to differ materially from those described herein includePROS' ability to develop new products and product enhancements with the required functionality desired and PROS' ability to implement and support successfully its products to the expectations of its customers. Additional information relating to the uncertainty affecting the PROS business is contained in PROS' filings with the Securities and Exchange Commission. These forward-looking statements represent PROS' expectations as of the date of this press release. Subsequent events may cause these expectations to change, and PROS disclaims any obligations to update or alter these forward-looking statements in the future, whether as a result of new information, future events or otherwise.